Acetylcholinesterase inhibitors for autistic spectrum disorders (Protocol)

Georgina R. Cox, Katrina J. Williams, Jade M. Woon, Richard Haslam, Alexandra M. Ure

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.

Original languageEnglish
Article numberCD013851
Number of pages17
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number1
DOIs
Publication statusPublished - 23 Jan 2021

Cite this